CERO
USDCERo Therapeutics Holdings Inc. Common Stock
Echtzeitkurs
Kursdiagramm
Schlüsselkennzahlen
Marktkennzahlen
Eröffnung
$0.335
Hoch
$0.095
Tief
$0.095
Volumen
8.44M
Unternehmensfundamentaldaten
Marktkapitalisierung
177.4K
Branche
Biotechnologie
Land
United States
Handelsstatistiken
Durchschnittliches Volumen
2.29M
Börse
NCM
Währung
USD
52-Wochen-Spanne
Ähnliche Nachrichten
Maxim Group Downgrades CERo Therapeutics Hldgs to Hold
Maxim Group analyst Jason McCarthy downgrades CERo Therapeutics Hldgs from Buy to Hold.
D. Boral Capital Maintains Buy on CERo Therapeutics Hldgs, Maintains $30 Price Target
D. Boral Capital analyst Jason Kolbert maintains CERo Therapeutics Hldgs with a Buy and maintains $30 price target.
CERo Therapeutics Announces Receipt of Nasdaq Panel Determination
Trading of the Company's shares of common stock on Nasdaq will be suspended at the open of trading on October 31 CERo plans to appeal the Panel determination, seek trading of its shares on the OTC Markets and continue
D. Boral Capital Maintains Buy on CERo Therapeutics Hldgs, Maintains $30 Price Target
D. Boral Capital analyst Jason Kolbert maintains CERo Therapeutics Hldgs with a Buy and maintains $30 price target.
CERo Therapeutics Announces Third Dose for Patient in Phase 1 Clinical Trial of CER-1236 in AML
Company completes first tranche of a $7 million financing to increase cash runway and maintain Nasdaq compliance SOUTH SAN FRANCISCO, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc.
CERo Therapeutics to Participate in Stem Cell Therapy Panel at the Maxim Growth Summit 2025
SOUTH SAN FRANCISCO, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) ("CERo" or the "Company"), an innovative cellular immunotherapy company, announces that Chris Ehrlich,
Ähnliche Aktien
Bleiben Sie auf dem Laufenden
Preisalarme setzen, KI-Analyse-Updates und Echtzeit-Marktnachrichten erhalten.